118 related articles for article (PubMed ID: 8137961)
21. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and "add-back" therapy.
Murray SC; Muse KN
Fertil Steril; 1997 Feb; 67(2):390-3. PubMed ID: 9022620
[TBL] [Abstract][Full Text] [Related]
22. Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism.
Heiner JS; Greendale GA; Kawakami AK; Lapolt PS; Fisher M; Young D; Judd HL
J Clin Endocrinol Metab; 1995 Dec; 80(12):3412-8. PubMed ID: 8530574
[TBL] [Abstract][Full Text] [Related]
23. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
Carr BR; Breslau NA; Givens C; Byrd W; Barnett-Hamm C; Marshburn PB
J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
[TBL] [Abstract][Full Text] [Related]
24. Evaluation and therapy of polycystic ovarian syndrome.
Loy R; Seibel MM
Endocrinol Metab Clin North Am; 1988 Dec; 17(4):785-813. PubMed ID: 3143568
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
Bertoli A; Fusco A; Magnani A; Marini MA; Di Daniele N; Gatti S; Lauro R
Exp Clin Endocrinol Diabetes; 1995; 103(1):15-20. PubMed ID: 7621099
[TBL] [Abstract][Full Text] [Related]
26. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
[TBL] [Abstract][Full Text] [Related]
27. Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study.
Bahçeci M; Ulug U; Ben-Shlomo I; Erden HF; Akman MA
J Reprod Med; 2005 Feb; 50(2):84-90. PubMed ID: 15755044
[TBL] [Abstract][Full Text] [Related]
28. Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission.
Carmina E; Lobo RA
Hum Reprod; 1997 Apr; 12(4):663-6. PubMed ID: 9159420
[TBL] [Abstract][Full Text] [Related]
29. Assessing new terminal body and facial hair growth during pregnancy: toward developing a simplified visual scoring system for hirsutism.
Yang Y; Han Y; Wang W; Du T; Li Y; Zhang J; Yang D; Zhao X
Fertil Steril; 2016 Feb; 105(2):494-500. PubMed ID: 26616440
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
Taskin O; Yalcinoglu AI; Kafkasli A; Burak F; Ozekici U
Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
[TBL] [Abstract][Full Text] [Related]
31. Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin).
Andreyko JL; Monroe SE; Jaffe RB
J Clin Endocrinol Metab; 1986 Oct; 63(4):854-9. PubMed ID: 2943756
[TBL] [Abstract][Full Text] [Related]
32. Treatment of hirsutism in women with flutamide.
Marcondes JA; Minnani SL; Luthold WW; Wajchenberg BL; Samojlik E; Kirschner MA
Fertil Steril; 1992 Mar; 57(3):543-7. PubMed ID: 1531466
[TBL] [Abstract][Full Text] [Related]
33. Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients.
Ciotta L; Cianci A; Marletta E; Pisana L; Aglianò A; Palumbo G
Fertil Steril; 1994 Dec; 62(6):1129-35. PubMed ID: 7957975
[TBL] [Abstract][Full Text] [Related]
34. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
Porcile A; Gallardo E
Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074
[TBL] [Abstract][Full Text] [Related]
35. Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatment.
Gram IT; Ursin G; Spicer DV; Pike MC
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1117-20. PubMed ID: 11700258
[TBL] [Abstract][Full Text] [Related]
36. Role of the ovary in the adrenal androgen excess of hyperandrogenic women.
Azziz R; Rittmaster RS; Fox LM; Bradley EL; Potter HD; Boots LR
Fertil Steril; 1998 May; 69(5):851-9. PubMed ID: 9591492
[TBL] [Abstract][Full Text] [Related]
37. Hirsutism.
Morris DV
Clin Obstet Gynaecol; 1985 Sep; 12(3):649-74. PubMed ID: 3905161
[TBL] [Abstract][Full Text] [Related]
38. [Clinical study on the effectiveness and safety of combined laparoscopy and gonadotropin-releasing hormone agonist in the treatment of endometriosis].
Song JH; Lu H; Zhang J; Li B
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):584-8. PubMed ID: 24199923
[TBL] [Abstract][Full Text] [Related]
39. Hirsutism.
Carpenter PC; Turk DM
Curr Ther Endocrinol Metab; 1994; 5():237-41. PubMed ID: 7704723
[No Abstract] [Full Text] [Related]
40. Gonadotropin-releasing hormone (GnRH) agonists and estrogen/progestin replacement for the treatment of hirsutism: evaluating the results.
Rittmaster RS
J Clin Endocrinol Metab; 1995 Dec; 80(12):3403-5. PubMed ID: 8530572
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
